THERAGEN ETEX CO.,LTD. Logo

THERAGEN ETEX CO.,LTD.

A biotech and pharma group for genome-based personalized and precision medicine.

066700 | KO

Overview

Corporate Details

ISIN(s):
KR7066700006
LEI:
Country:
South Korea
Address:
경기도 안산시 단원구 산단로 68번길 58(초지동), 안산시

Description

THERAGEN ETEX CO.,LTD. is a biotechnology and pharmaceutical group focused on genome-based personalized and precision medicine. The company integrates advanced genomic analysis with pharmaceutical development and manufacturing. Its genomics division provides comprehensive genetic analysis services, leveraging pioneering achievements such as creating the world's first female and tiger genome maps and commercializing Asia's first individual genome analysis service. The pharmaceutical division develops and supplies medicines from its international GMP-certified facilities. The R&D pipeline focuses on incrementally modified drugs, orphan drugs, and novel anticancer therapies, including its proprietary drug candidate, Vactosertib, which is in clinical trials for various cancers.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2025-12-30 00:00
[기재정정]영업실적등에대한전망(공정공시)
Korean HTML 16.4 KB
2025-08-14 00:00
반기보고서 (2025.06)
Korean HTML 1.6 MB
2025-07-30 00:00
영업(잠정)실적(공정공시)
Korean HTML 14.3 KB
2025-07-30 00:00
영업실적등에대한전망(공정공시)
Korean HTML 10.6 KB
2025-05-15 00:00
분기보고서 (2025.03)
Korean HTML 1.2 MB
2025-05-08 00:00
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean HTML 10.1 KB
2025-05-08 00:00
연결재무제표기준영업(잠정)실적(공정공시)
Korean HTML 16.9 KB
2025-05-08 00:00
영업(잠정)실적(공정공시)
Korean HTML 14.4 KB
2025-04-30 00:00
소속부변경
Korean HTML 3.6 KB
2025-04-22 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 24.1 KB
2025-04-18 00:00
증권발행결과(자율공시)
Korean HTML 5.6 KB
2025-04-10 00:00
[기재정정]주요사항보고서(전환사채권발행결정)
Korean HTML 94.8 KB
2025-03-27 00:00
정기주주총회결과
Korean HTML 19.8 KB
2025-03-24 00:00
[기재정정]주요사항보고서(유상증자결정)
Korean HTML 40.7 KB
2025-03-21 00:00
주식등의대량보유상황보고서(약식)
Korean HTML 99.7 KB

Automate Your Workflow. Get a real-time feed of all THERAGEN ETEX CO.,LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for THERAGEN ETEX CO.,LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for THERAGEN ETEX CO.,LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Aprogen, Inc Logo
Develops and manufactures biologic medicines, including biosimilars and novel drugs.
South Korea
007460
Develops drugs for intractable diseases by regulating oxidative stress and CAFs.
South Korea
293780
Aptamer Sciences Inc Logo
Clinical-stage company developing aptamer-based therapeutics for oncology.
South Korea
291650
Aptorum Group Ltd Logo
Clinical-stage biopharma developing therapeutics for oncology and infectious diseases.
United States of America
APM
Aquestive Therapeutics, Inc. Logo
Pharmaceutical company developing oral film medicines for CNS and allergic reactions.
United States of America
AQST
Arbutus Biopharma Corp Logo
Clinical-stage biopharma company developing a functional cure for chronic Hepatitis B.
United States of America
ABUS
Arcellx, Inc. Logo
A clinical-stage biotech company developing immunotherapies for cancer and autoimmune diseases.
United States of America
ACLX
Arctic Bioscience Logo
Develops pharmaceutical and nutraceutical products from marine membrane lipids.
Norway
ABS
ArcticZymes Technologies Logo
Develops and manufactures novel recombinant enzymes from Arctic marine organisms.
Norway
AZT
Arcturus Therapeutics Holdings Inc. Logo
A commercial-stage mRNA medicines company focused on rare and infectious diseases.
United States of America
ARCT

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.